<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03611387</url>
  </required_header>
  <id_info>
    <org_study_id>CCPMOH2018-China-4</org_study_id>
    <nct_id>NCT03611387</nct_id>
  </id_info>
  <brief_title>Artificial Intelligence Screening on Patients With Primary Angle Closure Glaucoma</brief_title>
  <acronym>AI</acronym>
  <official_title>Artificial Intelligence Screening on Patients With Primary Angle Closure Glaucoma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sun Yat-sen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of California</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Sun Yat-sen University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Tomey CASIA (Tomey Corporation, Nagoya, Japan) is a novel rapid imaging device that
      captures high-quality imaging of the entire anterior chamber of the eye over detailed imaging
      of a single section. In this prospective study, we want to investigate and compare the
      anatomical structure of the drainage angle of the eye in patients with different types
      glaucoma using Tomey machine. This study gives us a better understanding of the
      predictability, validity and accuracy of Tomey machine in the diagnosis of different types of
      glaucoma. Moreover, the data collected here will be used to create an artificial intelligence
      (AI) platform to screen certain type of glaucoma.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients ≥18 years old from ophthalmic clinics with or without glaucoma were enrolled to this
      respective observational clinical study. However, patients with any history of eye surgery
      (except cataract surgery) including laser procedure were excluded. The investigators will
      review patients' medical chart and update any medical history in your medical record. If new
      scans are needed, investigators will do them at the time of patients' current visit and it
      will require about 30 mins. CASIA SS-OCT (CASIA 2) is a non-contact scan of the front of the
      eye with higher resolution and provides deeper, wider and three- dimensional views. It is the
      newest scan machine. It is not FDA-approved but is approved in many other countries including
      Japan for patient use. We may perform the scan in the light and dark condition. We may also
      perform the routine scan to capture images of the anterior part of the eye for comparison
      purpose. The results of the scanned data will be among patients' medical records. Age, sex
      and ethnicity within your medical records will also be used for the analysis.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">April 1, 2018</start_date>
  <completion_date type="Anticipated">December 31, 2019</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2019</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Day</target_duration>
  <primary_outcome>
    <measure>The accuracy of the CASIA 2 OCT</measure>
    <time_frame>baseline</time_frame>
    <description>To compare the clinical applicability, accuracy, and validity of the CASIA 2 OCT (Tomey, Nagoya, Japan) in the assessment of anterior chamber angle of the eye in the glaucomatous patients withconventional imaging methods.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The sensitivity and specificity of the AI</measure>
    <time_frame>baseline</time_frame>
    <description>To create an AI program to reliably screen patients with certain type of glaucoma (such as primary angle closure glaucoma, PACG) using images from CASIA 2 OCT. To test the sensitivity and specificity of the AI program to screen patients with glaucoma using images from CASIA 2 OCT. Another database comprised of CASIA 2 OCT images will be created and used to test the AI program. The diagnosis based on the AI program will be compared with diagnosis from glaucoma specialist.</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">1500</enrollment>
  <condition>Ophthalmopathy</condition>
  <arm_group>
    <arm_group_label>Normal</arm_group_label>
    <description>Patients without any type of glaucoma</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Primary angle closure glaucoma</arm_group_label>
    <description>Patients with primary angle closure glaucoma</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Primary open-angle glaucoma</arm_group_label>
    <description>Patients with primary open-angle glaucoma</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CASIA 2 OCT</intervention_name>
    <description>Using CASIA 2 OCT to assess the anterior chamber angle of the eye in the glaucomatous patients withconventional imaging methods</description>
    <arm_group_label>Normal</arm_group_label>
    <arm_group_label>Primary angle closure glaucoma</arm_group_label>
    <arm_group_label>Primary open-angle glaucoma</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Outpatients ≥18 years old with or without glaucoma
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient with or without glaucoma

        Exclusion Criteria:

          -  Patients with any history of eye surgery (except cataract surgery) including laser
             procedure.

          -  Age &lt; =18 years
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jing Li, M.D</last_name>
    <phone>+86-20-87330341</phone>
    <email>Reviewborad_SYsU@163.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Haotian Lin, M.D,Ph.D</last_name>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Zhognshan Ophthalmic Center, Sun Yat-sen University</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510060</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Haotian Lin, M.D., Ph.D.</last_name>
      <phone>8613802793086</phone>
      <email>haot.lin@hotmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Jing Li, M.D.</last_name>
      <phone>+86-20-87330341</phone>
      <email>Reviewborad_SYsU@163.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>July 2018</verification_date>
  <study_first_submitted>July 26, 2018</study_first_submitted>
  <study_first_submitted_qc>July 26, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 2, 2018</study_first_posted>
  <last_update_submitted>July 26, 2018</last_update_submitted>
  <last_update_submitted_qc>July 26, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">August 2, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sun Yat-sen University</investigator_affiliation>
    <investigator_full_name>Haotian Lin</investigator_full_name>
    <investigator_title>Prof.</investigator_title>
  </responsible_party>
  <keyword>Primary Angle-Closure Glaucoma</keyword>
  <keyword>Artificial Intelligence</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glaucoma</mesh_term>
    <mesh_term>Glaucoma, Angle-Closure</mesh_term>
    <mesh_term>Eye Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

